Hospital
Mississippi County Hospital System
Mississippi County Hospital System was paid $3.26M by Medicaid between Jan 2018 and Dec 2024, across 143 billing codes. Its largest line is 80053, Comprehensive metabolic panel — 8.6% of everything it billed.
33Billing provider infoMISSISSIPPI COUNTY HOSPITAL SYSTEM
BLYTHEVILLE, AR 72315
BLYTHEVILLE, AR 72315
33aNPI1316180748assigned 04/15/2009
33bProvider typeGeneral Acute Care Hospital
28Total paid$3.26M
24GClaims240,987
24DCodes billed143
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Arkansas
Rank by total paid#21 of 49
Median peer was paid$2.62M
This provider vs. median1.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 32,587 | $418K | |
| 2019 | 38,205 | $511K | |
| 2020 | 26,925 | $345K | |
| 2021 | 35,569 | $490K | |
| 2022 | 37,703 | $539K | |
| 2023 | 36,344 | $513K | |
| 2024incomplete | 33,654 | $446K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 80053 | Comprehensive metabolic panel | 8.6% | 20,047 | 14,993 | $281K |
| 70450 | Computed tomography, head or brain; without contrast material | 8.0% | 2,686 | 2,343 | $260K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 5.4% | 2,653 | 2,047 | $178K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 5.4% | 22,549 | 17,714 | $177K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 4.4% | 1,135 | 957 | $143K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 3.9% | 2,829 | 2,197 | $128K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 3.8% | 2,369 | 1,823 | $125K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 3.8% | 1,757 | 1,496 | $125K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2.8% | 4,598 | 808 | $90K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 2.7% | 3,497 | 3,224 | $89K |
| 80305 | 2.5% | 6,884 | 5,481 | $82K | |
| 83880 | 2.3% | 3,127 | 2,698 | $76K |
131 more codes
| 99284 | Emergency room visit (serious) | 2.2% | 2,362 | $73K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2.1% | 5,809 | $69K |
| 71045 | Radiologic examination, chest; single view | 1.9% | 7,487 | $62K |
| 99285 | Emergency room visit (most serious) | 1.6% | 2,098 | $52K |
| 71046 | Radiologic examination, chest; 2 views | 1.4% | 2,840 | $45K |
| 84484 | 1.4% | 4,938 | $45K | |
| 83874 | 1.3% | 3,100 | $41K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.2% | 3,594 | $40K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 1.2% | 799 | $40K |
| 87081 | 1.2% | 4,758 | $40K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.1% | 4,006 | $36K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 1.1% | 162 | $35K |
| 76801 | <1% | 890 | $32K | |
| 87430 | <1% | 2,812 | $32K | |
| 81001 | <1% | 13,770 | $31K | |
| 86901 | <1% | 1,424 | $31K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 5,321 | $31K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 2,807 | $30K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 2,581 | $30K |
| 82805 | <1% | 1,066 | $28K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 513 | $24K |
| 80050 | General health panel | <1% | 497 | $24K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 3,209 | $23K |
| 81025 | <1% | 2,740 | $23K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 2,533 | $21K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 145 | $20K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 2,588 | $20K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 2,874 | $20K |
| 73562 | <1% | 850 | $19K | |
| 83605 | <1% | 1,806 | $19K | |
| 85027 | <1% | 3,061 | $18K | |
| 82550 | <1% | 2,663 | $18K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 1,962 | $17K |
| 83690 | <1% | 2,393 | $17K | |
| 83735 | <1% | 2,783 | $17K | |
| 87400 | <1% | 2,785 | $16K | |
| 94760 | <1% | 752 | $14K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 3,630 | $14K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 1,585 | $13K |
| 80061 | Lipid panel | <1% | 1,234 | $13K |
| 85730 | <1% | 2,656 | $13K | |
| 87040 | <1% | 1,172 | $13K | |
| 86756 | <1% | 778 | $13K | |
| 80320 | <1% | 864 | $13K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,394 | $11K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 67 | $11K |
| 97161 | <1% | 163 | $11K | |
| 59025 | Fetal non-stress test | <1% | 103 | $11K |
| 82150 | <1% | 1,334 | $11K | |
| 84702 | <1% | 1,012 | $10K | |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 124 | $10K |
| 84703 | <1% | 890 | $10K | |
| 85610 | <1% | 3,197 | $10K | |
| G0378 | Hospital observation service, per hour | <1% | 91 | $9K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 57 | $9K |
| 87807 | <1% | 705 | $9K | |
| 99218 | <1% | 184 | $9K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 3,161 | $8K |
| 87077 | <1% | 680 | $6K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 2,618 | $6K |
| 73630 | <1% | 333 | $6K | |
| 87186 | <1% | 625 | $6K | |
| 85378 | <1% | 918 | $6K | |
| 86900 | <1% | 1,366 | $5K | |
| 74018 | <1% | 320 | $5K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,667 | $5K |
| 73030 | <1% | 289 | $5K | |
| T1015 | A visit at a community health center or clinic (one all-in rate) | <1% | 1,445 | $4K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 331 | $4K |
| 36415 | Collection of venous blood by venipuncture | <1% | 8,303 | $4K |
| 71250 | <1% | 41 | $4K | |
| 80362 | <1% | 528 | $4K | |
| 73610 | <1% | 251 | $4K | |
| 82728 | <1% | 618 | $4K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 479 | $3K |
| 83615 | <1% | 684 | $3K | |
| 97597 | <1% | 170 | $3K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 108 | $3K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 46 | $3K |
| 80329 | <1% | 145 | $2K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 96 | $2K |
| 72100 | <1% | 113 | $2K | |
| 70486 | <1% | 15 | $2K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 1,516 | $2K |
| 82565 | <1% | 165 | $2K | |
| 86850 | <1% | 437 | $2K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 67 | $1K |
| 96367 | <1% | 197 | $1K | |
| 82962 | <1% | 232 | $1K | |
| 73130 | <1% | 59 | $1K | |
| 83540 | <1% | 319 | $1K | |
| 83550 | <1% | 267 | $1K | |
| 71010 | <1% | 441 | $884.37 | |
| 71020 | <1% | 74 | $882.31 | |
| 74022 | <1% | 34 | $768.00 | |
| 73502 | <1% | 40 | $739.75 | |
| J1815 | Injection, insulin, per 5 units | <1% | 272 | $627.02 |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 42 | $595.00 |
| 93971 | <1% | 17 | $474.97 | |
| 76641 | <1% | 12 | $464.74 | |
| 73110 | <1% | 13 | $457.99 | |
| 76818 | <1% | 39 | $450.84 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 1,447 | $440.00 |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 15 | $383.81 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 382 | $339.43 |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 710 | $287.05 |
| 84436 | <1% | 47 | $222.50 | |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | <1% | 64 | $206.60 |
| 84520 | <1% | 26 | $188.53 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 21 | $180.49 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | <1% | 2,080 | $133.66 |
| 86140 | <1% | 30 | $120.24 | |
| 82009 | <1% | 22 | $107.80 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 237 | $96.27 |
| J2704 | Injection, propofol, 10 mg | <1% | 641 | $92.21 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 133 | $92.02 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 259 | $77.61 |
| 82947 | <1% | 14 | $72.80 | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 155 | $71.08 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 99 | $66.24 |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 74 | $43.48 |
| 36600 | <1% | 280 | $43.12 | |
| J3105 | Injection, terbutaline sulfate, up to 1 mg | <1% | 53 | $32.40 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,624 | $16.53 |
| J0360 | Injection, hydralazine hcl, up to 20 mg | <1% | 105 | $11.66 |
| J7510 | Prednisolone oral, per 5 mg | <1% | 25 | $6.22 |
| 96376 | <1% | 329 | $4.49 | |
| 36416 | 0% | 157 | $0.00 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 24 | $0.00 |
| J7030 | Infusion, normal saline solution , 1000 cc | 0% | 177 | $0.00 |
| 93041 | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialRAYMER, CHRIS (COO/CNO)
| Provider | Location | Paid |
|---|---|---|
| Mississippi County Hospital System | Blytheville, AR | $1.19M |
| Mississippi County Hospital System | Osceola, AR | $27K |
| Mississippi County Hospital System | Blytheville, AR | $21K |
| Mississippi County Hospital System | Blytheville, AR | $4K |
| Mississippi County Hospital System | Blytheville, AR | $117.39 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.